Tempus will manage sample collection and NGS services to support potential commercialization of intismeran autogene for melanoma and other cancers. Financial terms not disclosed.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
